Namer Balilah

Strategy and Biotechnology

He works on strategy and biotechnology at the Strategy Management Office and is listed among the senior management team of Hevolution Foundation as Executive Director of Development. Hevolution is a Saudi non-profit dedicated to extending human healthspan and funding ageing and geroscience research, having directed hundreds of millions of dollars to more than two hundred laboratories worldwide. His work intersects with the National Biotechnology Strategy launched by the Kingdom in 2024 to localise innovation in biomanufacturing, genomics and advanced therapies, and to build national capability in a sector that brings together research, investment and regulation.